RGS 0.00% 12.0¢ regeneus ltd

stem cell biotechnology company

  1. 2,285 Posts.
    lightbulb Created with Sketch. 513
    Regeneus (ASX:RGS) listed today on the ASX.

    Stem Cell technology breakthroughs continue to ramp up the space.

    RGS is funded for the next 2 years. IPO was at 25 cents, oversubscribed, with about 70m shares listed.

    Impressive list of biotech directors and management.

    Has had some very impressive breakthroughs with animal models (as the video from channel 9's report shows).

    Hopefully, these successes can be repeated in human trials, if so, the potential for generating profits from stem cell injections for arthritis is enormous.

    If you are a biotech investor, and especially if you are interested in stem cell technology (ie. MSB, ECQ, AHZ etc), then put this on your watch list and do some research.



    Gw

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.